ARUN SREEKUMAR to Treatment Outcome
This is a "connection" page, showing publications ARUN SREEKUMAR has written about Treatment Outcome.
Connection Strength
0.007
-
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood. 2009 Sep 24; 114(13):2733-43.
Score: 0.007